Navigation Links
Penn-Wistar team gains insight into HIV vaccine failure
Date:7/20/2009

PHILADELPHIA (July 20, 2009) A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast doubt on the feasibility of HIV-1 vaccines. The findings were published on-line July 20 in Nature Medicine.

The phase II STEP vaccine trial was stopped after an interim analysis showed no efficacy in preventing HIV infection in at-risk individuals. It was noted that a subset of participants who had previous immunity in the form of neutralizing antibodies to the adenovirus 5 (Ad5) vector used to deliver the vaccine actually showed a trend toward an increased rate of HIV infection. Finding an explanation for this increased susceptibility to infection remains a major focus for HIV vaccine researchers.

These individuals were found to have high blood Ad5 neutralizing antibody (nAb) titers, the main immune gatekeeper in most vaccine strategies. Antibodies produced in response to previous infection neutralize viruses by binding to them and preventing their entry into host cells. They work in concert with other immune cells, including CD4 T-cells, which build a memory bank against future infection. In HIV infection, the virus attaches specifically to CD4 receptors on activated CD4 T-cells, establishing a stronghold and replicating.

Of the STEP findings, many researchers hypothesize that the T-cells of individuals in this high-Ad5-antibody group were activated by the Ad5-vaccine vector, creating more activated CD4 T-cells which then served as targets for the HIV virus to establish an infection.

"Our findings disprove the favored hypothesis," says co-lead author Hildegund C.J. Ertl, M.D., director of The Wistar Institute Vaccine Center. "There was nothing to indicate that pre-existing neutralizing antibodies correlated with numbers of activated CD4 T-cells to Ad5, which could
'/>"/>

Contact: Susan I. Finkelstein
sfinkelstein@wistar.org
215-898-3943
The Wistar Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. Cells united against cancer
2. Voice Biometrics Gains Traction as Most Accurate and Convenient Technology to Secure Customer Privacy
3. Progress Against Malaria: Developments on the Horizon
4. Genes that both extend life and protect against cancer identified
5. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
6. Gamma interferon could aid fight against fungal infections
7. In the laboratory, green tea proves a powerful medicine against severe sepsis
8. Omega-3 fatty acids protect against Parkinsons, study says
9. Protein protects brain against compound in lead poisoning, liver disease
10. Blood pressure drug telmisartan shows powerful activity against stroke
11. CWRU School of Medicine has evidence vaccine against malaria will reduce disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2015)... 23, 2015 SoundView Technology Group issues a new ... NXTD ) Wocket smart wallet. SoundView was one of the selected ... experience with the Wocket in multiple scenarios and outlets. ... and other retailers, making both debit and credit card payments.  ... says, "If the company meets their plans in 2015, it ...
(Date:3/23/2015)... 23, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, announces its biometric payment technology, the ... CNBC television starting March 30 th . ... New York markets. ... excited about our new ad campaign following the recent initial ...
(Date:3/20/2015)... , March 20, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... is one of the products featured in 2015 "I ... at 11:00 PM EST on the DIY Network.   ... Las Vegas , site of the 2015 ...
Breaking Biology News(10 mins):Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 2NXT-ID's Wocket Smart Wallet to Launch New CNBC Regional TV Ad Campaign 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... hydrogels developed by Carnegie Mellon University researchers may ... The hydrogels, created by Newell Washburn, Krzysztof Matyjaszewski ... growth of preosteoblast cells, cells that aid the ... Bencherif will present this research, Sunday, Aug. 17 ...
... Mich. Scientists at Michigan State University have ... The discovery could ultimately lead to plant varieties ... are specialized compartments in plant cells, convert sunlight, ... ("fuel" for the plant) during photosynthesis. The newly ...
... new methods for following the trail of dangerous carbon emissions ... threats. , ... is no universally accepted way of calculating someone,s carbon footprint, ... in the past few years creating confusion and inaccurate information. ...
Cached Biology News:Hydrogels provide scaffolding for growth of bone cells 2MSU's discovery of plant protein holds promise for biofuel production 2Carnegie Mellon urges industry to broaden carbon footprint calculations 2
(Date:4/30/2015)...  Pfenex Inc. (NYSE MKT: PFNX) a clinical-stage ... therapeutics including high value and difficult to manufacture ... announced underwritten public offering of 6,750,000 shares of ... of $15.50 per share. This includes the exercise ... to purchase up to 750,000 additional shares of ...
(Date:4/30/2015)... Available in select spas in ... , Phytomer’s DOUCEUR INTEMPORELLE Restorative Shield Cream provides ... battling the weakening threat of inflammaging, aging directly ... with star ingredient GLYCOSEA, a complex of restructuring ... of soothing minerals and trace elements. GLYCOSEA works ...
(Date:4/29/2015)... BALTIMORE, Maryland, USA (PRWEB) April 29, 2015 ... photonics, optical sensing, and imaging on the East Coast, ... government program managers, researchers, applications developers, and industry suppliers ... sensing and imaging for multiple applications. , The event ... security, and commercial and scientific sensing and imaging -- ...
(Date:4/29/2015)... (PRWEB) April 29, 2015 The leading ... announce that its regenerative stem cell therapy has processed ... 2002, seeking to discover a successful treatment for horses ... In 2003 VetStem signed a worldwide exclusive license for ... and the first horse was treated in January 2004. ...
Breaking Biology Technology:Pfenex Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 3SPIE DSS provides venue for collaboration vital to research, applications advances 2SPIE DSS provides venue for collaboration vital to research, applications advances 3SPIE DSS provides venue for collaboration vital to research, applications advances 4VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples 2
... Cord Blood America, Inc . (OTC Bulletin Board: ... Cord Blood America,s CEO and Co-Founder Matthew Schissler has been ... Authority.  The Biotech Committee is charged with developing programs and ... and help existing biotech companies expand in the area. ...
... Calif., Jan. 31, 2011 Onyx Pharmaceuticals, Inc. (Nasdaq: ... Food and Drug Administration (FDA) has granted fast track ... the potential treatment of patients with relapsed and refractory ... by the FDA to facilitate the development, and expedite ...
... Fox Chase Cancer Center , one of the nation,s leading cancer ... outcomes data to its website as a tool to assist ... follows on a survey Fox Chase commissioned in the fall of ... that would be the most important ...
Cached Biology Technology:Cord Blood America CEO and Co-Founder Matthew Schissler Named Chairman of Biotech Committee for Nevada Development Authority 2Onyx Pharmaceuticals Receives Fast Track Designation for Carfilzomib; Company Initiates Rolling NDA Submission for Accelerated Approval 2Onyx Pharmaceuticals Receives Fast Track Designation for Carfilzomib; Company Initiates Rolling NDA Submission for Accelerated Approval 3Onyx Pharmaceuticals Receives Fast Track Designation for Carfilzomib; Company Initiates Rolling NDA Submission for Accelerated Approval 4Fox Chase Cancer Center Publishes Clinical Outcomes for Patient Use 2Fox Chase Cancer Center Publishes Clinical Outcomes for Patient Use 3
... Yersinia pestis This antibody is ... Immunogen: Purified F1 ... vaccine strain EV76. Specificity: ... capsular antigen. There is no cross-reactivity ...
Phospho-SEK1/MKK4 (Thr261) Antibody...
Rabbit polyclonal to Leucyl tRNA synthetase ( Abpromise for all tested applications). Antigen: L930-H1176 denatured human recombinant LRS. Entrez Gene ID: 3926 Swiss Protein ID: Q9P2J5...
Phospho-FADD (Ser194) Antibody (Human Specific)...
Biology Products: